Impact of elevated glucose levels on cardiac function in STEMI patients: glucose delta as a prognostic biomarker
In STEMI patients undergoing pharmacoinvasive treatment, a higher glycemic delta was associated with greater infarct size and lower LVEF. This straightforward glycemic parameter provides valuable prognostic insight for both diabetic and non-diabetic populations.
Authors
- Ibraim Pinto (ORCID: https://orcid.org/0000-0002-0886-0844)
- Henrique Tria Bianco (ORCID: https://orcid.org/0000-0001-6746-8327)
- Adriano Henrique Pereira Barbosa (ORCID: https://orcid.org/0000-0001-6936-9162)
- Maria Cristina de Oliveira Izar (ORCID: https://orcid.org/0000-0002-5738-2623)
- Gilberto Szarf (ORCID: https://orcid.org/0000-0002-1941-7899)
- Francisco Antônio Helfenstein Fonseca (ORCID: https://orcid.org/0000-0002-9911-4598)
- Attílio Galhardo (ORCID: https://orcid.org/0000-0002-8340-7302)
- Bernardo F. Garcia
- Adriano Caixeta (ORCID: https://orcid.org/0000-0002-6287-5414)
Institutions
- Hospital Israelita Albert Einstein (BR)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Université Laval (CA)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1186/s13098-025-01738-0
- Citations
- 1
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- AstraZeneca
- Fundação de Amparo à Pesquisa do Estado de São Paulo